Patti Sullivan Selected Research

3,4-dihydroxyphenylacetaldehyde

11/2017	N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
9/2016	3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
2/2016	Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.
12/2012	Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patti Sullivan Research Topics

Disease

15	Parkinson Disease (Parkinson's Disease) 01/2024 - 12/2012
6	Orthostatic Hypotension (Postural Hypotension) 03/2024 - 01/2017
5	Multiple System Atrophy 01/2024 - 01/2017
4	Pure Autonomic Failure 01/2024 - 01/2017
4	Pheochromocytoma 01/2018 - 02/2016
3	Synucleinopathies 01/2022 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2015
2	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 09/2015
1	Dizziness (Lightheadedness) 01/2024
1	Neurodevelopmental Disorders 01/2018
1	Dementia (Dementias) 01/2018
1	Disease Progression 11/2017
1	Hypertension (High Blood Pressure) 02/2016

Drug/Important Bio-Agent (IBA)

9	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 12/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
5	CatecholaminesIBA 01/2022 - 12/2012
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2024 - 01/2019
4	alpha-SynucleinIBA 03/2024 - 01/2017
4	3,4-dihydroxyphenylacetaldehydeIBA 11/2017 - 12/2012
3	Aldehyde DehydrogenaseIBA 01/2022 - 08/2014
3	Monoamine Oxidase (MAO)IBA 11/2017 - 02/2016
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 04/2015
2	RotenoneIBA 01/2022 - 04/2015
2	SynucleinsIBA 01/2022 - 12/2012
2	Selegiline (E250)FDA LinkGeneric 11/2017 - 09/2016
1	hydroxide ionIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022
1	DroxidopaIBA 01/2019
1	quinone (benzoquinone)IBA 01/2018
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 09/2016
1	rasagiline (Azilect)FDA Link 09/2016
1	Clorgyline (Clorgiline)IBA 09/2016
1	TyramineIBA 02/2016
1	Dihydroxyphenylalanine (Dopa)IBA 09/2015
1	BenomylIBA 08/2014

Therapy/Procedure

4	Denervation 01/2017 - 12/2012
2	Sympathectomy (Sympathectomies) 01/2018 - 01/2017